Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for NCNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 25.89M
March 31, 2026 28.39M
December 31, 2025 32.62M
September 30, 2025 33.99M
June 30, 2025 11.57M
March 31, 2025 5.102M
December 31, 2024 8.452M
September 30, 2024 15.23M
June 30, 2024 14.71M
March 31, 2024 16.26M
December 31, 2023 21.96M
September 30, 2023 21.73M
June 30, 2023 31.33M
March 31, 2023 38.33M
December 31, 2022 50.42M
September 30, 2022 56.65M
June 30, 2022 56.51M
Date Value
March 31, 2022 69.20M
December 31, 2021 81.62M
September 30, 2021 95.77M
June 30, 2021 101.43M
March 31, 2021 108.48M
December 31, 2020 119.41M
September 30, 2020 130.16M
June 30, 2020 59.06M
March 31, 2020 59.02M
December 31, 2019 68.84M
September 30, 2019 71.59M
June 30, 2019 82.95M
March 31, 2019 91.09M
December 31, 2018 98.03M
September 30, 2018 102.17M
June 30, 2018 107.56M
March 31, 2018 114.10M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
Mereo BioPharma Group Plc 30.12M
BioNTech SE 16.89B
Silence Therapeutics Plc 72.05M
Autolus Therapeutics Plc 203.13M